Stay updated on RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer
Sign up to get notified when there's something new on the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page.

Latest updates to the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 error page without study-record content.SummaryDifference0.2%

- Check31 days agoChange DetectedThe study record area displays a 403 Forbidden message with a Home link instead of study content.SummaryDifference0.5%

- Check44 days agoChange DetectedAccess to the study record page now shows a 403 Forbidden error, replacing the normally visible trial details with a generic error screen. This blocks core content and prevents viewing trial information on that page.SummaryDifference20%

Stay in the know with updates to RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer
Enter your email address, and we'll notify you when there's something new on the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page.